Will killing the last HIV1 particle cure AIDS patients? Doesn't CMV activation and/or a graft-versus-host component of the disease, also have to be considered? I. First of two parts

Biomedicine and Pharmacotherapy

Volumn 50, Issue 5, 1996, Pages 185-206

  Mathe, G ^a  

^a Hopital Suisse de Paris   (France)

Author keywords

CMV; GvH; HIV1 AIDS components

Indexed keywords

ACRIFLAVINE; ANTIVIRUS AGENT; CYTOKINE; DIDANOSINE; SAQUINAVIR; ZALCITABINE; ZIDOVUDINE; CD57 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD TRANSFUSION; CHIMERA; CYTOMEGALOVIRUS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; AIDS RELATED COMPLEX; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CYTOMEGALIC INCLUSION BODY DISEASE; EDITORIAL; IMMUNOLOGY; LYMPHOCYTE COUNT; PATHOLOGY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, CD57; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS INFECTIONS; GRAFT VS HOST DISEASE; HIV-1; HUMANS; LYMPHOCYTE COUNT;

EID: 0029658676     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/0753-3322(96)87659-1     Document Type: Editorial

References (140)

1. Gottlieb MS Groopman JF Weinsten WM The acquired immunodeficiency syndrome Ann Int Med 99 1981 208
2. Curan JW Evatt BL Lawrence GDN The acquired immune deficiency syndrome: the past as prologue Ann Int Med 98 1983 401
3. Mathé G Le SIDA 1995 La Coutellerie Paris
4. Mathé G Le SIDA et son association avec des tumeurs et virus humains. Cause virale et/ou immunogénétique? Biomed Pharmacother 37 1983 153
5. Mathé G Graft versus host and auto-immune reactions may explain the discontinuity and severity of HIV1-AIDS disease? Biomed Pharmacother 48 1994 1
6. Mathé G Bernard J Larrieu MJ Essai de traitement de sujets atteints de leucémie aiguë en rémission par irradiation suivie de transfusion de moelle osseuse homologue Rev Franç Etudes Clin Biol 4 1959 675
7. Mathé G Bernard J De Vries MJ Nouveaux essais de greffe de moelle osseuse homologue après irradiation totale chez les enfants atteints de leucémie aiguë en rémission. Problème du syndrome secondaire chez l'Homme Rev Hematol 15 1960 111
8. Mathé G Amiel JL Cattan A Schneider M Haematopoietic chimera in man after allogeneic (homologous) bone marrow transplantation. Control fo the secondary syndrome. Specific tolerance due to the chimerism Br Med J 2 1963 1633
9. Mathé G Amiel JL Successful allogeneic bone marrw transplantation in man. Chimerism, induced specific tolerance and possible antileukemic effects Blood 25 1965 179
10. Mathé G Amiel JL Schwarzenberg L Bone Marrow Transplantation and Leukocyte Transfusions 1971 Thomas Springfield
11. Mathé G Bone marrow transplantation to day for aplasias and leukemias The Role of Immunological Factors in Viral and Oncogenic Processes 1 1974 John Hopkins University Press Baltimore 85
12. Mathé G Bernard J Essai de traitement de la leucémie greffée L 1210 par l'irradiation X suivie de transfusion de cellules hématopoiétiques normales (isologues, lymphoides ou myéloides, adultes ou embryon-naires) Rev Franç Etudes Clin Biol 4 1959 442
13. Mathé G Amiel JL Bernard J Traitement de souris AkR à l'âge de 6 mois par irradiation totale suivie de transfusion de cellules hématopoiétiques homologues. Incidences respectives de la leucémie et du syndrome secondaire Bull Cancer 47 1960 331
14. Mathé G Amiel JL Adoptive immunotherapy of acute leukemia. Experimental and clinical results Cancer Res 25 1965 1525
15. Rosenberg S Observation of the systemic administration of autologous lymphokine activated killer cells and interleukine 2 to patients with metastatic cancer N Engl J Med 313 1985 1485
16. Barnes DWH Loutit JF Treatment of murine leukemia with X-rays and homologous bone marrow Br J Haemal 3 1957 241
17. Van Bekkum DW Vos O Weyzen WWH The pathogenesis of secondary disease after foreign bone marrow transplantation in X irradiated mice J Nat Cancer Inst 23 1959 75
18. Congdon CC Pathologic findings in the delayed heterologous bone marrow reaction Rad Res 7 1957 310
19. Mathé G Amiel JL L'aplasie myeloïde de l'irradiation totale 1965 Gauthier-Villard Paris
20. Mathé G Amiel JL Niemetz J Greffe de moelle osseuse après irradiation totale chez des souris leucémiques, suivie de l'administration d'un cytostatique pour réduire la fréquence du syndrome secondaire et ajouter à l'effet antileucémique Bull OMS 26 1962 692
21. Santos GW Tutschka PJ Brookmeyer R Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide N Engl J Med 309 1983 1347
22. Blume KG Forman SJ O'Donnel MR Total body irradiation and high-dose etoposide: A new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies Blood 69 1987 1015
23. Rimm AA Barr JT Horowitz MM Bortin MM The use of a clinical data registry to evaluate medical technologies: Experience from the International Bone Marrow Transplant Registry Int J Technol Assess Health Care 7 1991 182
24. Thomas ED Storb E Clift RA Bone marrow transplantation N Engl J Med 292 1975 832
25. Weiden PL Flournoy N Thomas ED Antileukemic effect of graft versus host disease in marrow transplantation N Engl J Med 300 1979 1068
26. Mathé G Jammet H Transfusion et greffe de moelle osseuse homologue chez des humains irradiés à haute dose accidentellement Rev Franç Etudes Clin Biol 4 1959 226
27. Salmon C Technique d'appréciation quantitative de 2 populations d'hématies chez 4 sujets irradiés à haute dose et traités par transfusion de moelle osseuse Rev Franç Clin Biol 4 1959 239
28. Strober S Slavin S Gottlieb M Allograft tolerance after total lymphoid irradiation Immunologic Review 46 1979 87
29. Mathé G Amiel JL Greffe de moelle osseuse allogénique chez l'Homme, prouvée par six marqueurs anti-géniques, après conditionnement du receveur et du donneur par le sérum anti-lymphocytaire Rev FrançEtudes Clin Biol 13 1960 1025
30. Monaco AP Wood ML Russel PS Studies of heterologous anti-lymphocyte serum in mice: Immunolgic tolerance and chimerism produced accross the H2 locus with adult thymectomy and anti-lymphocyte serum Ann NY Acad Sci 129 1966 190
31. Mathé G De Vries MJ Amiel JL Les divers aspects du syndrome secondaire compliquant les transfusions de moelle osseuse ou de leucocytes allogéniques chez des sujets atteints d'hémopathies malignes Eur J Cancer 1 1965 75
32. Mathé G Schwarzenberg L The graft versus host reaction after while blood cells transfusions Mathé G While Blood Cell Transfusion Paris 1970 CNRS
33. Burgess MA Garson OM Homologous leukocyte transfusion in acute leukaemia with cytogenic evidence of a myeloid graft Med J Austr 3 1969 1243
34. Niethammer D Goldmann SF Flad HD Graft versus-host reaction after blood transfusion in a patient with cellular immuno-deficiency. The role of histocompatibility vestig Eur J Pediatr 132 1979 43
35. Leboit PE Transfusion-associated graft versus host disease Hum Pathol 18 1987 414
36. Schechter GP Wang-Peng J McFarland W Circulation of donor lymphocytes and graft versus host disease Arch Dis Child 46 1971 571
37. Growe JP Gordon NH Fry DE Breast cancer survival and peri-operative blood transfusion Surgery 106 1989 836
38. Siimes MH Koshimies S Chronic graft versus-host disease after blood transfusions confirmed by incompatible HLA antigens in bone marrow Lancet 1 1982 42
39. Dinsmore RE Straus DJ Pollack MS Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing Blood 55 1980 831
40. Berger RS Dixon SL Fulminant transfusion associated GvH in a premature infant J Am Acad Dermatol 20 1989 947
41. Githens JH Muschenheim F Fulginiti VA Thymic alymphoplasia with XX/XY lymphoid chimerism secondary to possible maternal-foetal transfusion Pediatrics 75 1969 87
42. Da Costa H Amiel JL Mathé G Immunisation contre des greffes de cellules hématopoïétiques allogéniques par des transfusions de sang antérieures Vox Sanguinis 9 1964 420
43. Salvatierra O Vicenti F Amend W Deliberate donor specific blood transfusion prior to living renal transplantation: a new approach Ann Surg 192 1980 543
44. Demetris AJ Murase N Starzl TE Hematolymphoid cell trafficking, microchimerism an FGvHD reaction after liver, bone marrow and heart transplantation Transplantation Proc 25 1993 3337
45. Murase N Starzl TE Tanabe M Varaible chimerism, graft versus host disease and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown-Norway rats Transplantation 60 1995 158
46. Starzl TE Demetris AJ Murase N Cell migration chimerism and graft acceptance Lancet 339 1992 1579
47. March Starzl TE Demetris AJ Murase N The last chord: microchimerism Immunol Today 1996 5
48. Halle-Pannenko O Zalc-Gouget C Kuroiwa A Bourut C Mathé G II. Effects of four specific agents: anti-recognition structure serum, host and donor-directed sera and host soluble H-2 antigens Int J radiation Oncology Biol Phys 1 1976 927
49. Shelly J Maruschack MN Nelson EW Prostaglandin and suppressor cell induction in transfusion-induced immune suppression Transplantation 43 1987 113
50. Dempster WJ Lennox B Boag JW Prolongation of survival of skin homotransplants in the rabbit by irradition of the host Br J Exp Pathol 31 1950 670
51. Kuss R Legrain M Mathé G Etude de 4 cas d'irradiation totale par le cobalt radio-actif (à des doses de 250 –400 and 600 rads) préalable à une transplantation rénale allogénique Rev Franç Etudes Clin Biol 7 1962 1028
52. Murray JE Merrill JP Damain GJ Kidney transplantation in modifier recipients Ann Surg 156 1962 337
53. Hamburger J Vaysse J Crosnier J Six tentatives d'homotransplantation rénale chez l'Homme après irradiation du receveur Rev Franç Etudes Clin Biol 6 1962 20
54. Ebbesen P Biggar RJ Melbye M Aids A basic Guide for Clincians 1984 Smunksgaard Philadelphia
55. Rosen CB Ng CS Moore SB Clinical, pathologic feature of graft versus host disease after liver transplantation. A case report and review of the literature Clin Transpl 7 1993 52 58
56. Barré-Sinoussi F Chermann JC Rey F Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science 220 1983 868
57. Clavel F Guétard D Brun-Vézinet F Isolation of a new human retrovirus from West African patients with AIDS Science 233 1986 343
58. Temin HM Is HIV unique or merely different? J Acq Immun Def Synd 2 1989 1
59. Duesberg P Human immunodeficiency virus and acquired immuno-deficiency syndrome: correlation but not causation Proc Natl Acad Sci 86 1989 755
60. Lange JMA Persistant HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS Br Med J 293 1986 1459
61. Moss AR Bachetti P Natural history of HIV infection AIDS 3 1989 55
62. + T-lymphocytopenia without HIV infection. An investigation of cases in the United States N Engl J Med 328 1993 373
63. + T-lymphocytopenia. Immunodeficiency without evidence of HIV infection N Engl J Med 328 1993 380
64. Buchbinder SP Long term MHIV infection without immunologic progression AIDS 8 1994 1123
65. Piot P Kapita BM Nguyi EN Le Sida en Afrique 1993 WHO Geneva
66. Penneys NS Manifestations cutanée du SIDA 1991 Flammarion Paris
67. Montagnier L Rosenbaum W Gluckman JC SIDA et infections VIH 1989 Flammarion Paris
68. Saag MS Holodniy M Kuritzkes DR HIV viral load markers in clinical practice Nat Med 2 1996 625
69. Shilts R And the Band Played 1987 St Martin's Press New York
70. Zager RA, O'Quigley J, Zager BK, et al Acute renal failure following bone marrow transplantation. A retrospective study of 272 patients. Am J Kidney Quoted by Calabresi P
71. Morris L Distenfield A Amoro S Auto-immune thrombocytopenic purpura in homosexuals Ann Intern Med 96 1982 714
72. Reichert CM O'Leary TJ Levens DL Autopsy pathology in AIDS Am J Path 112 1983 357
73. Weiner RS Bortin MM Gale RP Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors Ann Inter Med 104 1986 168
74. Tarro G Perna A Patologia dell'AIDS 1991 VIBO Valentia Mapograf
75. Sanders JE Thomas ED Buckner CD Growth and development following marrow transplantation for leukemia Blood 68 1986 1129
76. Jones RJ Lee KSK Beschorner WE Veno-oclusive disease of the liver following bone marrow transplantation Transplantation 44 1987 778
77. McIvor C Morton J Fatal reactivation of precoce mutant hepatitis B virus associated with fibrosis cholestatic hepatitis after bone marrow transplantation Ann Intern Med 121 1994 27476
78. Niedobitek G Young SL Epstein-Barr virus persistence and virus-associated tumours Lancet 343 1994 333
79. Petersen JM Tubbs RR Savage RA Small noncleaved B cell Burkitt-like lymphoma with chromosome t (8;14) translocation and Epstein-Barr virus nuclear-associated antigen in a homosexual man with acquired immune deficiency syndrome Am J Med 78 1985 141
80. Chaganti RSK Jhanwar SC Koziner B Specific translocations characterize Burkitt's-like lymphoma of homosexual men with the acuired immunodeficiency syndrome Blood 61 1983 1269
81. Mathé G La prévention des cancers génito-anaux et bucco-laryngo-eosophagiens à virus transmis sexuellement Biomed Pharmacother 39 1985 253
82. Melbge M Coté TR Kessler L High incidence of anal cancer among AIDS patients Lancet 343 1994 636
83. Van Den Berg FM Schipper M Jiwa M Implausibility of an etiological association between cytomegalovirus and Kaposi's sarcoma shown by four techniques J Clin Pathol 42 1989 128
84. Liebelt A Malignant neoplasms in organ transplantation Levine AS Etiology of Cancer in Man 1989 Kluver Dordrecht
85. Chang J Lesarman E Pessin MS Identification of Herpes virus-like DNA sequences associated Kaposi sarcoma Science 206 1994 1865
86. + suppresor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation J Immunol 137 1986 2180
87. Favrot M Janossy G Tidman N T-cell regeneration after allogeneic bone marrow transplantation Clin Exp Immunol 54 1983 59
88. + lymphocytes when HIV, p24 antigen reappears in the blood Biomed Pharmacother 48 1994 3
89. Drew WL Cytomegalovirus infection in patients with AIDS J Infect Dis 158 1988 449
90. De la Tribonnière X L'infection au HHV6I Lettre del'Infectiol 9 1994 10
91. Davis GL Hepatitis B and C: influence of immunodepression Topic Supportive Cares 4 1991 2
92. Kelen GD Green GB Purcell RH Hepatitis B and hepatitis C in emergency department patients N Engl J Med 326 1992 1399
93. Esiri MM Scaravilli F Millard RP Neuropathology of HIV infection in haemophiliacs: comparative necropsy study Br Med J 299 1989 1312
94. Donaldson YD Bell JE Ironside JW Redistribution of HIV outside the lymphoid system with onset of AIDS Lancet 343 1994 382
95. Levy JA Shimabukuro J McHugh T AIDS-associated retrovirus (ARV) can productively infect other cells besides human T helper Virology 147 1985 441
96. Popovic M Gartner S Isolation of HIV-1 from monocytes but not T-lymphocytes Lancet ii 1987 916
97. Ullum H Gotzsche PC Victor J Defective natural immunity: an early manifestation of human immunodeficiency, virus infection J Exp Med 182 1995 789
98. Fauci AS Immunologic abnormalities in the acquired immuno-deficiency syndrome Clin Res 32 1985 491
99. Amman AJ Mother-infant HIV transmission: making the most of what we know Nat Med 2 1996 490
100. Ilaria G Jacobs J Polsky B Detection of HIV-DNA sequence in pre-ejaculation fluid Lancet 340 1992 1469
101. Datta P Embree JE Kreiss JK Resumption of breast feeding in later childhood: a risk factor for mother to child human immuno-deficiency virus type 1 transmission Pediatr Infect Dis J 11 1992 974
102. Alexander NJ Sexual transmission of human immunodeficiency virus: virus entry into the male and female genital tract Fertil Steril 54 1990 1
103. Shearer GM Allogeneic leukocytes as a possible factor in induction of AIDS in homosexual men N Engl J Med 308 1983 233
104. Rudert WA Kocava M Rao AS Fine qualification by competitive PCR of circulating donor cells in post-transplant chimeric recipients Transplantation 59 1994 964
105. Pollack MS Kirkpatrick D Kapoor N Identification by HLA typing of intra-uterine-derived maternel T cells in four patients with severe combined immunodeficiency N Engl J Med 307 1982 662
106. Seman G Technique personnelle de coloration des lobules hétéro-chocatiques des leucocytes, spécialement des mononuclées. Valeur de cette technique par la détermination du sexe Rev Franç Etudes Clin Biol 6 1961 161
107. Starzl TE Demetris AJ Systemic chimerism in female recipient of livers Lancet 340 1992 876
108. 1-AIDS complex 1996
109. Moffat EH Furlong RA Dannatt AH Anti-idiotypes to factor VIII antibodies and heir possible role in the pathogenessis and treatment of factor VIII inhibitors Br J Haematol 71 1989 85
110. Rossi F Sultan YM Kazatchkine MD Anti-idiotypes against auto-antibodies and alloantibodies to anti-haemophilic factor are present in therapeutic polyspecific normal immunoglobulins Clin Exp Immunol 74 1988 311
111. Tiarks C Ghalili K Humphreys RF Identification of six functional clotting factor VIII: C epitopes by analysis of croos-reactive public idiotypes in murine monoclonal VIII: C inhibitors Thromb Res 45 1987 527
112. Smid WM Van Der Meer J Smit JW The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate Thromb Haemost 69 1993 306
113. Kion TA Hoffmann GW Anti-HIV and anti-MHC antibodies in alloimmune and autoimmune mice Science 253 1991 1138
114. Hoffmann GW Kion TA Grant MD An idiotypic network model of AIDS immunopathogenesis Proc Natl Acad Sci 88 1991 3060
115. Laudin K Holmberg V CD4 mimiking antibodies in HIV-positive and normal human sera J AIDS 5 1992 658
116. Olsson L Mathé G Immune reactions with cytotoxic activity to “self” in naturel surveillance of aberrant cells Biomedicine 30 1979 281
117. Roncarolo MG Yssel H Touraine JL Batuel H De Vries JF Spits H Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera J Exp Med 167 1988 1523
118. Gratama JW Kardol M Naipal AM The influence of CMV carrier status on lymphocyte subsets and natural immunity Clin Exp Imm 68 1987 16
119. + cells in normal, healthy individuals: correlation with human CMV carrier status, phenotypic and functional analysis Clin Exp Med 94 1993 297
120. Verdonk LF De Gast GC Is cytomegalovirus infection a major cause of T cell alterations after (autologous) loone marrow transplantation? Lancet ii 1984 932
121. Drew WL Mintz L Miner RC Prevalence of cytomegalovirus infection inhomosexual men J Infec Dis 143 1981 188
122. Rinaldo CRJ Carneys WP Richeter BS Mechanisms of immuno-suppression in CMV mononucleosis J Inf Dis 141 1980 488
123. Jeantils V Lemaitre MO Robert J Subacute polyneutropathy with encephalopathy in AIDS with human cytomegalovirus pathogenicity? Lancet 1986 ii;1039
124. Moskowitz LB Gregorios JB Hensley GT Berger JR Cytomegalovirus: induced demyelination with AIDS Arch Pathol Lab Med 108 1984 873
125. Leach CT Cherry JD English PA The relationship between T-cell levels and CMV infection in asymptomatic HIV1 antibody positive homosexual men J Acquir Immune Defic Syndr 6 1993 407
126. Wu BC Dowling JN Armstrong JA Enhancement of mouse CMV infected during host versus host reaction Science 190 1975 56
127. Webster A Cook DG Emery VC Cytomegalovirus infection and progression towards AIDS in haemophiliacs with HIV infection Lancet i 1989 63
128. (in press) Mathé G Correlation between activated (blastoid) lymphocytes on peripheral blood smears of HIV-AIDS complex patients, and CMV infection Biomed Pharmacother 50 1996
129. Fischl MA Richman DD Hansen N The safety and efficacy of zidovudine (AZT) in the treatment of mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a double-blind, placebo-controlled trials Ann Inter Med 112 1990 727
130. Executive summary: dideoxyinosine/dideoxycytidineCPCRA study Community Programs for Clinical Research on AIDS January 15,1993
131. Mathé G Huppert J Chenu E Bourut C Amino-acridines action on Friend's virus retrovirus in relation to their-molecular ionization Biomed Pharmacother 43 1989 235
132. Mathé G Kim-Triana B Antiviral phase 1 trial of acriflavine in HIV1 infected patients Sixth International Conference on AIDS San Francisco 1990
133. Mathé G Pontiggia P A screening model of anti-HIV non AZT cross resistant virostatics Biomed Pharmacother 47 1993 461
134. Mathé G Chenu E Bourut C The in vivo effect of ellipticine analogues on the blood concentration of Friend's virus: a murine model for studying anti-HIV drugs Biomed Pharmacother 47 1993 457
135. (in press) Mathé G Hallard M Lymphography and viral change for methyl-hydroxy-ellipticine phase 2 study Biomed Pharmacother 50 1996
136. Fosse P René B Le Bret Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative Nucleic Acid Res 19 1991 2861
137. (in press) Mathé G Pontiggia P Orbach-Arbouys S Triana K Ambetima N Morette C Hallard M Blanquet D AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue Biomed Pharmacother 1996
138. Kitchen VS Skinner C Arignoshi K Safety and activity of saquinavir in HIV infection Lancet 345 1995 952
139. Danner SA Carr A Leonard JM A short-term study of the safety, pharmacokinetics efficacy of ritonavir, an inhibitor of HIV, protease. European Australian Collaborative Ritonavir Study Group N Engl J Med 333 1995 1528
140. Mellors JW Rinaldo CR Jr Gupta P White RM Todd JA Kingsley LA Prognosis in HIV-1 infection predicted by the quantity of virus in plasma Science 272 1996 1167